Related references
Note: Only part of the references are listed.C-reactive protein among community-dwelling hypertensives on single-agent antihypertensive treatment
Tibor Fulop et al.
JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION (2009)
Blood pressure control in Italy: results of recent surveys on hypertension
Massimo Volpe et al.
JOURNAL OF HYPERTENSION (2007)
Antihypertensive medications and C-reactive protein in the multi-ethnic study of atherosclerosis
Walter Palmas et al.
AMERICAN JOURNAL OF HYPERTENSION (2007)
Effects of blood pressure reduction on cardiovascular risk estimates in hypertensive postmenopausal women
R. A. Preston
CLIMACTERIC (2007)
Morbidity and mortality after stroke, eprosartan compared with nitrendipine for secondary prevention -: Principal results of a prospective randomized controlled study (MOSES)
J Schrader et al.
STROKE (2005)
Evaluation of C-reactive protein measurement for assessing the risk and prognosis in ischemic stroke - A statement for health care professionals from the CRP pooling project members
M Di Napoli et al.
STROKE (2005)
Antihypertensive medications prescribed at discharge after an acute ischemic cerebrovascular event
B Ovbiagele et al.
STROKE (2005)
Relationship between C-reactive protein and progression of early carotid atherosclerosis in hypertensive subjects
H Hashimoto et al.
STROKE (2004)
Association between blood pressure and C-reactive protein levels in acute ischemic stroke
M Di Napoli et al.
HYPERTENSION (2003)
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
AV Chobanian et al.
HYPERTENSION (2003)
C-reactive protein, carotid intima-media thickness, and incidence of ischemic stroke in the elderly - The Cardiovascular Health Study
JJ Cao et al.
CIRCULATION (2003)
The ACCESS study -: Evaluation of acute candesartan cilexetil therapy in stroke survivors
J Schrader et al.
STROKE (2003)
Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials
MR Law et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
High sensitivity C-reactive protein as an independent risk factor for essential hypertension
KC Sung et al.
AMERICAN JOURNAL OF HYPERTENSION (2003)
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure - The JNC 7 Report
AV Chobanian et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE):: a randomised trial against atenolol
B Dahlöf et al.
LANCET (2002)
Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack (Vol 358, pg 1033, 2001)
LANCET (2001)
Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack
S MacMahon et al.
LANCET (2001)
Ineffective secondary prevention in survivors of cardiovascular events in the US population - Report from the Third National Health and Nutrition Examination Survey
AI Qureshi et al.
ARCHIVES OF INTERNAL MEDICINE (2001)
Is C-reactive protein an independent risk factor for essential hypertension?
LE Bautista et al.
JOURNAL OF HYPERTENSION (2001)
Antithrombotic and antihypertensive management 3 months after ischemic stroke - A prospective study in an inner city population
T Hillen et al.
STROKE (2000)
Share Paper
